how age as a prognostic factor affects treatment options for all
Published 4 years ago • 26 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
1:31
how the treatment and management of all changes with age
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
2:45
an insight into clinical risk factors for progression in mpns
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:25
a-hipi, a novel prognostic model for advanced hl & outcomes of elderly patients with hl in australia
-
3:31
a summary of the prognostic factors that can influence the outcomes of anti-cd19 car-t in r/r dlbcl
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
1:45:26
one-stage assay of factor viii (fviii) - lab manual video
-
9:25
mgus diagnosis: a step-by-step approach
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
6:07
novel prognostic index for pediatric all
-
3:10
phase ii study of all-oral aaa regimen for patients with newly diagnosed apl
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
1:26
current and emerging prognostic factors for mds/mpn
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
1:37
transplantation: a holistic approach
-
2:20
ultra high-risk myeloma
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
6:21
prognostic significance of pet-ct status after first line immuno-chemotherapy for fl
-
4:25
cll: state of the art in italy